Astragaloside IV protects human cardiomyocytes from hypoxia/reoxygenation injury by regulating miR-101a

Astragaloside IV (AS/IV) is one of the extracted components from the traditional Chinese medicine Astragalus which has been demonstrated to have potential capacity for anti-inflammation activity and for treating cardiovascular disease. Our purpose was to determine the function and underlying molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yang, Fan, Zongjing, Chen, Zhengju, Hu, Jiqiang, Cui, Jie, Liu, Yang, Wang, Yao, Guo, Bin, Shen, Juan, Xie, Liandi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272390/
https://www.ncbi.nlm.nih.gov/pubmed/32394311
http://dx.doi.org/10.1007/s11010-020-03743-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272390/
https://www.ncbi.nlm.nih.gov/pubmed/32394311
http://dx.doi.org/10.1007/s11010-020-03743-5

Ejemplares similares